Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies.

52W Range

3rdpctl

Volume

0.81×avg

Market Cap

6.72MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Imunon, Inc.

IMNNNASDAQ Capital Market·USD·Closed

Imunon, Inc.

IMNNNASDAQ·USD·Closed

$1.60

+0.00%

$1.60

+$0.00 (0.00%)

52W Range

3rdpctl

Volume

0.81×avg

Mkt Cap

6.72MUSD

P/E

-0.4TTM

Div Yield

–ann

IMNN: Imunon, Inc. Stock Analysis | finqOS